Published in Protein Sci on June 01, 1997
Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase. EMBO J (2003) 1.31
Crystal structure of human uroporphyrinogen decarboxylase. EMBO J (1998) 1.26
A mouse model of familial porphyria cutanea tarda. Proc Natl Acad Sci U S A (2001) 1.11
Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. PLoS One (2012) 1.08
Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives. Clin Genet (2009) 0.92
Substrate shuttling between active sites of uroporphyrinogen decarboxylase is not required to generate coproporphyrinogen. J Mol Biol (2009) 0.83
Crystal structure of uroporphyrinogen decarboxylase from Bacillus subtilis. J Bacteriol (2006) 0.81
Prokaryotic Heme Biosynthesis: Multiple Pathways to a Common Essential Product. Microbiol Mol Biol Rev (2017) 0.77
Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases. Cell Mol Biol (Noisy-le-grand) (2009) 0.75
Solvent content of protein crystals. J Mol Biol (1968) 106.07
Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. J Biol Chem (1986) 2.05
Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyrinogens I and III. J Biol Chem (1983) 1.50
DETERMINATION OF STOICHIOMETRY AND EQUILIBRIUM CONSTANTS FOR REVERSIBLY ASSOCIATING SYSTEMS BY MOLECULAR SIEVE CHROMATOGRAPHY. Proc Natl Acad Sci U S A (1965) 1.48
Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase. Biochemistry (1983) 1.20
Purification of uroporphyrinogen decarboxylase from human erythrocytes. Immunochemical evidence for a single protein with decarboxylase activity in human erythrocytes and liver. Biochem J (1983) 1.11
Uroporphyrinogen decarboxylase. A method for measuring enzyme activity. Enzyme (1982) 1.10
Mutational analysis of human uroporphyrinogen decarboxylase. Biochim Biophys Acta (1996) 0.93
Uroporphyrinogen decarboxylase purification from chicken erythrocytes. Methods Enzymol (1986) 0.87
Studies on uroporphyrinogen decarboxylase of etiolated Euglena gracilis Z. Eur J Biochem (1989) 0.83
Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell (1996) 6.74
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science (1997) 6.10
Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature (2000) 5.60
Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res (2000) 4.34
Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med (1988) 3.66
Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J Mol Biol (1997) 3.50
Structural basis for the activation of 20S proteasomes by 11S regulators. Nature (2000) 3.04
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity. J Clin Invest (1976) 2.83
Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J (1999) 2.79
Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution. Acta Crystallogr D Biol Crystallogr (1999) 2.77
Regulation of HeLa cell transferrin receptors. J Biol Chem (1982) 2.46
Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J Biol Chem (1998) 2.44
Screening for hemochromatosis. N Engl J Med (1993) 2.32
Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution. EMBO J (1997) 2.29
Penicillin acylase has a single-amino-acid catalytic centre. Nature (1995) 2.18
Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med (1996) 2.15
Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest (1992) 2.08
Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc Natl Acad Sci U S A (1987) 2.02
Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol (2001) 1.92
Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med (2000) 1.84
High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia (2006) 1.81
Internalization and subcellular localization of transferrin and transferrin receptors in HeLa cells. J Biol Chem (1983) 1.80
Structure of the C-terminal domain of FliG, a component of the rotor in the bacterial flagellar motor. Nature (1999) 1.76
Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med (1994) 1.71
Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol (1982) 1.61
Iron absorption in hypotransferrinemic mice. Blood (1991) 1.58
Structure of the proteasome activator REGalpha (PA28alpha). Nature (1997) 1.56
Identification of an activation region in the proteasome activator REGalpha. Proc Natl Acad Sci U S A (1998) 1.54
Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. J Biol Chem (1997) 1.47
The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase. J Clin Invest (1975) 1.45
Heme regulation of HeLa cell transferrin receptor number. J Biol Chem (1984) 1.40
Hereditary haemochromatosis. Clin Haematol (1982) 1.38
Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. Protein Sci (1997) 1.36
Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol (2000) 1.35
Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet (1997) 1.31
Homogeneous multiplex genotyping of hemochromatosis mutations with fluorescent hybridization probes. Am J Pathol (1998) 1.30
Structure of a new crystal form of tetraubiquitin. Acta Crystallogr D Biol Crystallogr (2001) 1.28
Idiopathic refractory sideroblastic anemia: clinical and laboratory investigation of 17 patients and review of the literature. Medicine (Baltimore) (1971) 1.26
Crystal structure of human uroporphyrinogen decarboxylase. EMBO J (1998) 1.26
Comparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly. Protein Sci (1996) 1.26
Crystal structure of human uroporphyrinogen III synthase. EMBO J (2001) 1.23
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol (2001) 1.21
Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase. Biochemistry (1983) 1.20
Porphyria cutanea tarda in three generations of a single family. N Engl J Med (1978) 1.19
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood (2000) 1.14
Allelic association under map error and recombinational heterogeneity: a tale of two sites. Proc Natl Acad Sci U S A (1998) 1.13
A mouse model of familial porphyria cutanea tarda. Proc Natl Acad Sci U S A (2001) 1.11
The 11S regulators of 20S proteasome activity. Curr Top Microbiol Immunol (2002) 1.11
Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood (1995) 1.10
Uroporphyrinogen decarboxylase. A method for measuring enzyme activity. Enzyme (1982) 1.10
Successful treatment of a cardiac angiosarcoma with combined modality therapy. J Heart Lung Transplant (1995) 1.09
Evidence for a quantum phase transition in Pr2-xCe(x)CuO4-delta from transport measurements. Phys Rev Lett (2004) 1.09
The role of iron in the pathogenesis of porphyria cutanea tarda. An in vitro model. J Clin Invest (1972) 1.06
Crystal structure of the Saccharomyces cerevisiae ubiquitin-conjugating enzyme Rad6 at 2.6 A resolution. J Biol Chem (1998) 1.06
Hereditary hemochromatosis: contributions of genetic analyses. Prog Hematol (1981) 1.06
Crystal structure of Tritrichomonas foetus inosine-5'-monophosphate dehydrogenase and the enzyme-product complex. Biochemistry (1997) 1.05
Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med (1989) 1.03
Transferrin receptors of human fibroblasts. Analysis of receptor properties and regulation. Biochem J (1982) 1.03
Sterols in blood of normal and Smith-Lemli-Opitz subjects. J Lipid Res (2001) 1.01
Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med (1984) 1.01
Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation. Cancer (1979) 1.00
Laboratory diagnosis of the porphyrias. N Engl J Med (1991) 0.99
A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda. Blood (1989) 0.99
Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda. J Clin Invest (1990) 0.99
Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol (1999) 0.98
Expression, purification and crystallization of penicillin G acylase from Escherichia coli ATCC 11105. Protein Eng (1990) 0.95
Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda. Toxicol Appl Pharmacol (1997) 0.95
Crystal structures of adenine phosphoribosyltransferase from Leishmania donovani. EMBO J (1999) 0.93
Mutational analysis of human uroporphyrinogen decarboxylase. Biochim Biophys Acta (1996) 0.93
Fulminant amebic meningoencephalitis due to Acanthamoeba. Neurology (1981) 0.93
Preserving the national blood supply. Hematology Am Soc Hematol Educ Program (2001) 0.92
Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase. Blood (2001) 0.91
The enzymatic decarboxylation of the naturally occurring isomers of uroporphyrinogen by human erythrocytes. J Lab Clin Med (1979) 0.91
Mapping the locus for hereditary hemochromatosis: localization between HLA-B and HLA-A. Am J Hum Genet (1986) 0.91
Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda. J Lab Clin Med (2000) 0.90
Clostridial species in the pathogenesis of necrotizing enterocolitis in patients with neutropenia. Am J Hematol (1983) 0.90
Biosynthesis of porphyrin precursors. Purification and characterization of mammalian L-alanine:gamma,delta-dioxovaleric acid aminotransferase. J Biol Chem (1980) 0.90
Identification of the IMP binding site in the IMP dehydrogenase from Tritrichomonas foetus. Biochemistry (1995) 0.88
Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis. Diabetologia (2006) 0.87
Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. Gastroenterology (1993) 0.87
Congenital erythropoietic porphyria, diminished activity of uroporphyrinogen decarboxylase and dyserythropoiesis. Blood (1982) 0.86
Defining polyubiquitin chain topology. Nat Struct Biol (2001) 0.86
Transferrin receptor function in hereditary hemochromatosis. J Lab Clin Med (1984) 0.86
Detergent-assisted oxidative folding of delta-conotoxins. J Pept Res (2003) 0.86
Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda. Gastroenterology (1985) 0.86
Iron overload in hereditary spherocytosis: association with HLA-linked hemochromatosis. Am J Hematol (1982) 0.85
Assignment of uroporphyrinogen decarboxylase (UROD) to the pter----p21 region of human chromosome 1. Cytogenet Cell Genet (1985) 0.85
Structural diversity in metal ion chelation and the structure of uroporphyrinogen III synthase. Biochem Soc Trans (2002) 0.84
Elevated methionine-tRNA synthetase activity in human colon cancer. Proc Soc Exp Biol Med (1976) 0.84
The enzymatic defect in porphyria cutanea tarda. N Engl J Med (1982) 0.84
Biosynthesis of porphyrin precursors: kinetic studies on mammalian L-alanine: gamma,delta-dioxovaleric acid aminotransferase. Int J Biochem (1980) 0.83
The proteasome 11S regulator subunit REG alpha (PA28 alpha) is a heptamer. Protein Sci (1997) 0.83